We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+5%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$348M
AUM Growth
+$2.22M
Cap. Flow
-$11.3M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.87%
Holding
199
New
16
Increased
16
Reduced
87
Closed
12

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$5.82M
2
CTAS icon
Cintas
CTAS
+$5.14M
3
OSK icon
Oshkosh
OSK
+$4.9M
4
HQY icon
HealthEquity
HQY
+$4.67M
5
TER icon
Teradyne
TER
+$4.62M

Top Sells

Rank Stock Value
1
PETS icon
PetMed Express
PETS
+$10.8M
2
LRCX icon
Lam Research
LRCX
+$6.62M
3
DHR icon
Danaher
DHR
+$5.11M
4
EXP icon
Eagle Materials
EXP
+$5.1M
5
NBL
Noble Energy, Inc.
NBL
+$4.41M

Sector Composition

Rank Sector Weight
1 Healthcare 18.88%
2 Industrials 14.93%
3 Technology 14.51%
4 Financials 13.13%
5 Communication Services 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HQY icon
26
HealthEquity
HQY
$8.73B
$5.07M 1.46%
+100,260
New +$4.67M
TER icon
27
Teradyne
TER
$56.9B
$4.97M 1.43%
+133,401
New +$4.62M
DY icon
28
Dycom Industries
DY
$12.5B
$4.8M 1.38%
55,910
-2,015
-3% -$170K
PFE icon
29
Pfizer
PFE
$142B
$4.59M 1.32%
135,588
-3,372
-2% -$108K
BMY icon
30
Bristol-Myers Squibb
BMY
$133B
$3.89M 1.12%
61,022
-1,324
-2% -$77.3K
NSC icon
31
Norfolk Southern
NSC
$75.3B
$3.68M 1.06%
27,844
-646
-2% -$78.5K
ED icon
32
Consolidated Edison
ED
$39.7B
$3.67M 1.05%
45,464
-1,250
-3% -$103K
VWO icon
33
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$3.33M 0.95%
76,337
-3,184
-4% -$138K
PEP icon
34
PepsiCo
PEP
$190B
$3.11M 0.89%
27,923
-800
-3% -$92.4K
SO icon
35
Southern Company
SO
$107B
$3.01M 0.87%
61,323
-1,620
-3% -$78.5K
D icon
36
Dominion Energy
D
$60.2B
$2.96M 0.85%
38,426
-25
-0.1% -$1.94K
TFC icon
37
Truist Financial
TFC
$63.1B
$2.83M 0.81%
60,406
-735
-1% -$33.8K
JPC icon
38
Nuveen Preferred & Income Opportunities Fund
JPC
$2.92B
$2.8M 0.8%
264,650
-10,100
-4% -$106K
ICUI icon
39
ICU Medical
ICUI
$4.35B
$2.79M 0.8%
14,995
+75
+0.5% +$13.1K
T icon
40
AT&T
T
$162B
$2.67M 0.77%
90,389
-4,535
-5% -$129K
INTC icon
41
Intel
INTC
$458B
$2.67M 0.77%
69,993
-170
-0.2% -$6.04K
AGN
42
DELISTED
Allergan plc
AGN
$2.64M 0.76%
12,870
-440
-3% -$102K
IP icon
43
International Paper
IP
$22.1B
$2.5M 0.72%
46,555
+629
+1% +$33.1K
DD icon
44
DuPont de Nemours
DD
$18.8B
$2.41M 0.69%
13,757
+11,603
+539% +$1.94M
VNQ icon
45
Vanguard Real Estate ETF
VNQ
$39.2B
$2.37M 0.68%
28,505
-655
-2% -$54.7K
LLY icon
46
Eli Lilly
LLY
$995B
$2.36M 0.68%
27,540
-1,050
-4% -$86.1K
VZ icon
47
Verizon
VZ
$198B
$2.29M 0.66%
46,217
-3,298
-7% -$155K
TRV icon
48
Travelers Companies
TRV
$78B
$2.24M 0.64%
18,256
-1,000
-5% -$125K
CSCO icon
49
Cisco
CSCO
$457B
$2.2M 0.63%
65,499
-2,074
-3% -$66K
CVX icon
50
Chevron
CVX
$384B
$2.12M 0.61%
18,040
+320
+2% +$34.9K
1
2
3 4 5

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q3 2017 Portfolio in Review

As of Q3 2017, Dixon Hubard Feinour & Brown held 199 positions worth $348M, up 0.64% from $346M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dixon Hubard Feinour & Brown withdrew a net $11.3M in Q3 2017, closing 12 positions and reducing 87 holdings. Its most notable exit was PetMed Express, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

Against the trend, Dixon Hubard Feinour & Brown opened a new position in Cintas worth $5.57M.

  • Dixon Hubard Feinour & Brown's largest Q3 2017 buy was Cintas: 154,360 shares worth $5.57M.
  • Dixon Hubard Feinour & Brown added most to Celgene Corp in Q3 2017, an estimated $5.82M increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2017 reduction was Meta Platforms (Facebook), cutting an estimated $337K.
  • Dixon Hubard Feinour & Brown fully exited PetMed Express in Q3 2017, selling an estimated $10.8M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 25% of its $348M portfolio in Q3 2017.
  • Dixon Hubard Feinour & Brown opened 16 new positions and closed 12 in Q3 2017.
  • Dixon Hubard Feinour & Brown's portfolio value rose 0.64% quarter-over-quarter to $348M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2017, filed 8 Nov 2017.